LY3405105 is an orally active CDK7 inhibitor with an IC50 of 92.8 nM. LY3405105 shows potential antineoplastic activity.
[1] Georgina P Sava, et al. Cancer Metastasis Rev. 2020 Sep;39(3):805-823.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 5mg | ¥614.00 | 现货 | 1 | |
| 25mg | ¥1,875.00 | 现货 | 1 |
















LY3405105 is an orally active CDK7 inhibitor with an IC50 of 92.8 nM. LY3405105 shows potential antineoplastic activity.
[1] Georgina P Sava, et al. Cancer Metastasis Rev. 2020 Sep;39(3):805-823.